Where percentage of deficiency was not specified, assumption of normal distribution and use of the reference range values specified in the study were used in one study to determine percentage of deficiency. A total of 316 studies were identified by the search strategy (Fig. 1). After evaluation of the title, abstract and application of the initial inclusion/exclusion criteria, 53 articles were deemed potentially relevant and obtained in full. Eleven of these papers complied with the final inclusion/exclusion criteria. Relevant data were extracted in regards to the vitamin B6. Table 1 describes the

current prevalence of vitamin B6 deficiency in the haemodialysis population. Of the six studies reporting biochemical measures, Doxorubicin solubility dmso vitamin B6 deficiency was shown to be between 24% and 56%. Table 2 Smad inhibitor identifies to what extent the process of dialysis reduces vitamin B6 levels. Dialysis was shown to reduce plasma levels by between 28% and 48% depending on the dialyser used. Table 3 compares the frequency of vitamin B6 deficiency to that of other B group vitamins. Table 4 summarizes advances

in renal medicine shown to negatively affect vitamin B6 status. Of the nine studies included in Tables 1–3, no study scored more than 7/10 on the PEDro scale. None could fulfil the full criteria related to randomized control trials, with no studies meeting criteria 3, 6 or 7. Most of the studies fulfilled criteria 8–11, indicating that most subjects undertook the designated dialysis and supplementation regimen. The interobserver reliability percentage was 97%. This systematic review identified that low

levels of vitamin B6 are common in the haemodialysis population. As shown in Table 1, without supplementation at least a third of patients studied have low levels of vitamin B6 before dialysis, with suboptimal levels being evident in up to half of this patient group.1,13,14,18–20 This figure could potentially be higher in the general haemodialysis population, given patients enrolled in studies are often more stable, and potentially better nourished.11 Consideration needs to be given to the effect of current dialysis technology on vitamin B6 levels, as outlined in Table 2.14,21,22 Previous studies have compared the use of high-flux and standard new haemodialysis on PLP levels. While it stands to reason that high flux dialysers can remove greater levels of PLP owing to its improved clearance of larger molecules,11 not all studies confirm this.3 The most recent study to compare high-flux and low-flux dialysers included in this review found no difference in PLP clearance. It suggested though that the improved technology of more permeable dialyser membranes, with larger surface areas, may cause increased losses of micronutrients including PLP with current dialysis procedures.